- B2C
- B2B
- Early StageStartup in initial stages
Hyasynth Bio Funding
Hyasynth Bio is active in the following markets / industries: biotechnology, pharmaceuticals and marijuana. The company has secured funding across 4 rounds and is valued at $0. Their most recent funding was raised on September 13, 2019.
Funding Rounds
A
$10000000S
$1035000
S
Undisclosed amountS
Undisclosed amountSeedMay 2014
Investors of Hyasynth Bio
CEO @perlarapbc • CEO @ Maggie's Pearl • Worked at @Experiment, @Princeton University • Studied at @Harvard University, @Columbia University
Rounds
S
S
Founded Elemental Machines, Misfit, AgaMatrix; PhD Cambridge University; Marshall Scholar
Organigram
Rounds
A
Founder WebHosting.com (acquired by AT&T), InQuent (acquired by private equity > web.com), VerticalScope (acquired > Torstar).
Anges Qubec (angesquebec.com)
Rounds
S
InnoStart Capital
Rounds
S
Early Stage Start ups in the Product Space or in Technology. Companies who can drive change in a market space or technology which can make us more productive.
Rounds
S
We run the startup development programs HAX, IndieBio, Chinaccelerator, MOX, and dlab
Rounds
S
S
Founded 3 companies, 2 acquired, one profitable and ongoing. MIT Phd
Rounds
S